PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-01-28

Date Title Company
28-Jan-2025 ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research ENA Respiratory
28-Jan-2025 Novadip reports 12-month results from phase 1b/2a trial of NVD003 to treat rare pediatric disease Congenital Pseudarthrosis of the Tibia Andrew Lloyd Associates
28-Jan-2025 Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow AccessWire
28-Jan-2025 Glidewell to Host Nine Symposia in 2025 AccessWire
28-Jan-2025 Unlocking Protein Potential: EvoSelect® and Directed Evolution Isomerase
28-Jan-2025 Isomerase and BugBiome Partner to Advance Sustainable Crop Protection via Targeted Novel Bioinsecticides Isomerase
28-Jan-2025 Isomerase Launches Isochassis - Microbial Hosts for Scalable Protein Production Isomerase
28-Jan-2025 Commit Biologics announces €5.5m seed financing extension investment by Korys to further develop its Bispecific Complement Engaging (BiCE™) platform Commit Biologics
28-Jan-2025 Next Generation Cancer Diagnostics Market Will Reach USD 42.0 Billion by 2034 Prophecy Market Insights
28-Jan-2025 Vect-Horus further strengthens leadership with appointment of strategy and finance executive Jérôme Berger to its Board of Directors Vect-Horus
28-Jan-2025 OncoZenge enters into SEK 30.2 million investment agreement with new strategic investor Sichuan Yangtian Bio-Pharmaceutical, intended to be carried out through directed share issues OncoZenge
28-Jan-2025 Burnout crisis: Why UK doctors are missing out on AI lifelines Corti / YouGov
28-Jan-2025 AGFA HealthCare at HIMSS 2025: Revolutionizing Enterprise Imaging with Innovation and Work-Life Balance AccessWire
28-Jan-2025 FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL) Merck
28-Jan-2025 Roche’s Itovebi demonstrated statistically significant and clinically meaningful overall survival benefit in a certain type of HR-positive advanced breast cancer Roche
28-Jan-2025 Roche announces new results from EMBARK demonstrating significant sustained benefits of Elevidys in ambulatory individuals with Duchenne muscular dystrophy (DMD) Roche
28-Jan-2025 Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP GSK
28-Jan-2025 Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP GSK
28-Jan-2025 Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies AstraZeneca
28-Jan-2025 AcceleDev Appoints Dr. Fu-An Kang as Vice President of Chemistry Research & Development AccessWire